D L Carlson Investment Group Inc Novartis Ag Transaction History

D L Carlson Investment Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 10, 2018	SELL	$64.91 - $73.36 $3.61 Million - $4.07 Million	-55,545 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$70.39 - $84.15 $1.25 Million - $1.5 Million	-17,825 Reduced 24.29%	55,545 $4.49 Million
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $1,084 - $1,164	-15 Reduced 0.02%	73,370 $6.16 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $5.44 Million - $5.67 Million	73,385	73,385 $6.3 Million

1,423

130M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $215B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

Stay updated on D L Carlson Investment Group Inc with notifications on news.